DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions
Year: 2015
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Jacalyn Rosenblatt, Richard M. Stone, Lynne Uhl, Donna Neuberg, Poorvi Somaiya, Dina Stroopinsky, Robin Joyce, James D. Levine, Jon E. Arnason, Katarina Luptakova, Malgorzata McMasters, Salvia Jain, David P. Steensma, Daniel J. DeAngelo, Ilene Galinsky, Aya Sato-Dilorenzo, Kristen Anna Palmer, Emma Logan, Mary Paty Bryant, Donald Kufe, David Avigan
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2587352117